8-K current report · filed Oct 21, 2026

Danaher Corporation (DHR) 8-K Current Report: October 21, 2026

Item 2.02Item EX-99.1DHR overview

Short answer

Danaher Corporation (DHR) filed an 8-K current report with the SEC on October 21, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Danaher announced financial results for the quarter ended September 25, 2026.

Danaher Corporation 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Danaher announced financial results for the quarter ended September 25, 2026
  • Earnings details and management commentary available in Exhibit 99.1
  • Quarterly results provide updated visibility into operating performance and financial condition

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $6.6B, up 8.5%, with core growth excluding respiratory testing accelerating to 5.5%
  • Net earnings $1.2B, or $1.71 diluted EPS, up 34.5%; adjusted EPS $2.11, up 11.5%
  • Diagnostics GAAP sales grew 17.0%, but acquisitions and divestitures reduced reported growth by 16.5 percentage points
  • Operating cash flow $1.9B and free cash flow $1.6B, up approximately 13.5% and 19.0% year-over-year
  • Full-year adjusted EPS guidance raised to $8.57-$8.62; Q4 respiratory revenue expected as approximately 150-basis-point headwind

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Danaher Corporation 8-K filings

Get the next DHR 8-K as it lands

Follow DHR for push alerts, or ask the research agent what this filing means.